ArticlePharmaceutical statistics2018

Subgroup-specific dose finding in phase I clinical trials based on time to toxicity allowing adaptive subgroup combination.

Andrew G Chapple et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.